Featured Reagent – Cystatin C
Featured Reagent – Cystatin C
Featured Reagent | Cystatin C
Back to Reagents Resource Hub >
Kidney Disease
Kidney disease is a huge global health crisis, increasing healthcare costs, mortality and morbidity rates. The global prevalence of chronic kidney disease (CKD) has continued to rise during a short lifespan. In 2016, 1 in 10, equivalent to 10 percent of the global population were identified with having CKD with the highest prevalence’s reported in Europe, the Middle East, East Asia and Latin America, estimated at 12 per cent and the lowest in South Asia, estimated at 7 percent1.
The early risk assessment of renal function is vital. In 1990, CKD was ranked the 27th leading cause of death in the Global Burden of Disease study2, rising to 18th 3 in 2010, 13th in 20132 and 12th by 2015. From 2005-2015, the overall CKD mortality rate has risen by 31.7 percent, accounting for 1.1 million deaths globally in 20154.
Inadequacies of Traditional CKD Biomarkers
The most commonly used screening test for renal impairment is creatinine. When testing for CKD using creatinine, certain factors must be taken into consideration, including: age, gender, ethnicity, and muscle mass. As such, black men and black women will present with higher creatinine levels compared to white men and white women respectively5.
Serum creatinine is not an adequate screening test for renal impairment in the elderly (65 years of age and over) due to their decreased muscle mass. As such, patients are misdiagnosed, thus, patients with severe renal failure are receiving suboptimal care6.
The main disadvantage of using creatinine to screen for renal impairment is that up to 50 percent of renal function can be lost before significant creatinine levels become detectable as creatinine is insensitive to small changes in the glomerular filtration rate (GFR). Consequently, treatment is not provided at the appropriate time which can be fatal, thus, an earlier and more sensitive biomarker for renal function is vital7.
Biological Significance
Cystatin C is a small (13 kDa) cysteine proteinase inhibitor, produced by all nucleated cells at a constant rate. Cystatin C travels through the bloodstream to the kidneys where it is freely filtered by the glomerular membrane, resorbed and fully catabolised by the proximal renal tubes. Consequently, cystatin C is the ideal biomarker of GFR function8.
Clinical Significance of Cystatin C
The National Institute for Health and Care Excellence (NICE) (2014) guidelines recommend cystatin C testing due to its higher specificity for significant disease outcomes than those based on creatinine. As such, eGFR cystatin C measurements will significantly reduce the number of misdiagnosed patients, thus reducing the overall CKD burden9.
In 2017, a systematic literature search found 3,500 investigations into cystatin C as a marker of GFR. The study concluded that eGFRcystatinc was a significantly more superior than eGFRcreatinine10.
Benefits of Cystatin C
The Randox cystatin C assay utilises the latex enhanced immunoturbidimetric method offering numerous key features:
A niche product from Randox meaning that Randox are one of the only manufacturers to provide the cystatin C test in an automated biochemistry format
An automated assay which removes the inconvenience and time consumption associated with traditional ELISA testing
Applications are available detailing instrument-specific settings for the convenient use of the Randox cystatin C assay on a wide range of biochemistry analysers
Liquid ready-to-use reagents for convenience and ease-of-use
Latex enhanced immunoturbidimetric method delivering high performance
Extensive measuring range for the detection of clinically important results
Complementary controls and calibrators available offering a complete testing package
Limited interference from Bilirubin, Haemoglobin, Intralipid® and Triglycerides
Cystatin C does not suffer from a ‘blind area’ like creatinine due to cystatin C’s sensitivity to small changes in GFR enabling the early detection renal impairment
An exceptional correlation coefficient of r=1.00 when compared against standard methods
References
[1] Bello, AK, et al. Global Kidney Health Atlas: A report by the Internal Society of Nephrology on the current state of organization and structures for kidney care across the globe. Brussels : Internal Society of Nephrology, 2017.
[2] Bikbov, Boris. Chronic kidney disease: impact on the global burden of mortality and morbidity. The Lancet. [Online] 2015. http://www.thelancet.com/campaigns/kidney/updates/chronic-kidney-disease-impact-on-global-burden-of-mortality-and-morbidity.
[3] National Kidney Foundation. Global Facts: About Kidney Disease. National Kidney Foundation. [Online] National Kidney Foundation, 2015. https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease#_ENREF_1.
[4] Neuen, Brendon Lange, et al. Chronic kidney disease and the global NCDs agenda. s.l. : BMJ Global Health, 2017.
[5] Lascano, Martin E and Poggio, Emilio D. Kidney Function Assessment by Creatinine-Based Estimation Equations. Cleveland Clinic. [Online] August 2010. [Cited: May 16, 2018.] http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/nephrology/kidney-function/.
[6] Swedko, Peter J, et al. Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients. Research Gate. [Online] February 2003. [Cited: May 6, 2018.] https://www.researchgate.net/publication/8243393_Serum_Creatinine_Is_an_Inadequate_Screening_Test_for_Renal_Failure_in_Elderly_Patients.
[7] Mishra, Umashankar. New technique developed to detect chronic kidney disease. Business Line. [Online] May 07, 2018. [Cited: May 17, 2018.] https://www.thehindubusinessline.com/news/science/new-technique-to-detect-chronic-kidney-disease/article23803316.ece.
[8] Chew, Janice SC, et al. Cystatin C-A Paradigm of Evidence Based Laboratory Medicine. NCBI. [Online] May 29, 2008. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533150/.
[9] National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management: 2 Implementation: getting started. NICE. [Online] January 2015. [Cited: April 19, 2018.] https://www.nice.org.uk/guidance/cg182/chapter/implementation-getting-started.
[10] Grubb, Anders. Cystatin C is Indispensable for Evaluation of Kidney Disease. NCBI. [Online] December 28, 2017. [Cited: April 19, 2018.] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746836/.
MORE FEATURED REAGENTS
For more featured reagents click VISIT
Title
Medlab Middle East
![Medlab Middle East 2020](https://www.randox.com/wp-content/uploads/2019/12/Medlab-Middle-East-2020-scaled.jpg)
Join us for Medlab Middle East 2020!
Randox Laboratories will be attending Medlab Middle East form the 3rd February – 6th February 2020. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the Dubai International Convention & Exhibition Centre at stand Z5.B10.
New Products
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
Acusera Infectious Disease Serology Controls
Randox Quality Control are pleased to announce the launch of our new Infectious Disease Serology Internal Quality Controls. Our portfolio includes Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more.
All samples are provided in a user-friendly, liquid ready-to-use format. This significantly reduces preparation time and the risk of pipetting errors.
There is approximately 1 million people in the USA living with HIV and around 15% of them are unaware they are infected (CDC, March 2019). Furthermore, the Centers for Disease Control and Prevention (CDC) estimate that around 39,000 new HIV infections are reported per year.
The impact of not only HIV but all infectious diseases is getting much greater. Therefore, laboratories now play a much more important role in providing accurate test results. This is a key component in controlling the spread of infections.
Reporting a false positive result has its own obvious implications, however, what about the consequences of reporting a false negative. This can be just as devastating to a person in terms of the treatment they will receive and even personal lifestyle changes for the patient in question.
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
Randox Stroke Biochip
The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.
Using Randox revolutionary patented Biochips, the Randox Stroke Biochip provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.
Benefits of the Randox Stroke Biochip
> Multiplex biochip for rapid stroke classification in under 30 minutes from a single plasma sample
> Complements and enhances existing CT scanning ensuring fast and accurate diagnosis
> Fast and accurate diagnostic classification between ischaemic and haemorrhagic stroke
> Simple 2 step process from sample entry to results
> Ensures better outcomes guaranteeing timely therapeutic intervention
![Home Page](https://www.randox.com/wp-content/uploads/2019/12/Home-Page-scaled-1024x280.jpg)
![Home Page](https://www.randox.com/wp-content/uploads/2019/12/Home-Page-scaled-1024x280.jpg)
Lipoprotein(a) [Lp(a)]
Lipoprotein(a) [Lp(a)] is described as “the most complex and polymorphic of the lipoprotein particles” 1. The biggest challenge that exists surrounding Lp(a) measurement is the heterogeneity of the apo(a) isoforms. Standardisation across calibrators is vital as the repeated KIV-2 units in Lp(a) act as multiple epitopes. A lack of standardisation could result in the underestimation of Lp(a) associated CVD risk 2.
Lp(a) assays that are standardised to the WHO/IFCC reference material, transferring values from mg/dl to nmol/l are more uniformed. The Denka Seiken Lp(a) assay is the most reliable commercially available Lp(a) assay, because 2:
- The isoform size variations are reduced as a range of calibrators from separate pools of serum were used which covered a range of Lp(a) concentrations.
- The isoform size and concentrations are inversely correlated better matching calibrants with test samples.
- Methods based on the Denka Lp(a) assay, calibrated in nmol/l and traceable to the WHO/IFCC reference material produced an acceptable bias compared with the Northwest Lipid Metabolism and Diabetes Research Laboratory (NLMDRKL) gold standard method.
HEART UK advocate the widespread clinical utility of Lp(a) to refine the CVD risk assessment. In doing so, HEART UK developed ten statements on Lp(a) (Table 1) utilising the 2016 ACC/AHA Clinical Guideline Recommendation Classification System, to assess the strength of the recommendation and aid in guiding the phrasing of the recommendation 2.
![table redesign](https://www.randox.com/wp-content/uploads/2019/12/table-redesign-scaled.jpg)
![table redesign](https://www.randox.com/wp-content/uploads/2019/12/table-redesign-scaled.jpg)
Key Features of the Randox Lp(a) Assay
- The Randox Lp(a) assay is one of the only methodologies on the market that detects the non-variable part of the Lp(a) molecule and therefore suffers minimal size related bias providing more accurate and consistent results. The Randox Lp(a) kit is standardised to the WHO/IFCC reference material (IFCC SRM 2B) and is closest in terms of agreement to the ELISA reference method.
- Five-point calibrator with accuracy-based assigned target values, and control are available, accurately reflecting the heterogeneity of the apo(a) isoforms present in the general population and offering a complete testing package.
- Measuring units are available in nmol/l which is more uniformed and recommended by HEART UK.
- Immunoturbidimetric method is highly sensitive and specific for the detection of Lp(a) in serum and plasma.
- Excellent correlation co-efficient of r=0.995 when compared against other commercially available methods.
- Excellent within run precision of <2.54%.
- Liquid ready-to-use format for convenience and ease-of-use.
- Applications available detailing instrument-specific settings for the convenient use of the Randox Lp(a) assay on a wide range of clinical chemistry analysers.
References
- Marcovina SM, Albers JJ. Lipoprotein (a) measurements for clinical application . Journal of Lipid Research 2019; 57(): 526-537.
- Cegla J, Dermot R, Neely G, France M, Ferns G, et al. HEART UK consensus statement on Lipoprotein(a): A call to action. Atherosclerosis 2019; 291(): 62-70.
![Reagents Hfab](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab.jpg)
![Reagents Hfab](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab.jpg)
![Reagents Hfab](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab.jpg)
H-FABP in CSA-AKI Testing
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a well-recognised postoperative complication of cardiac surgery and is the second most common cause of AKI in the ICU, occurring in up to 30% of patients. Higher pre-operative values of H-FABP were associated with a higher risk of developing AKI. Following adjustments of certain patient characteristics, the association of pre-operative H-FABP with the development of AKI remained significant. In fact, the researchers observed that a 1 unit increase in log H-FABP was associated with a 3-fold increase in the odds of developing AKI.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
The new Evidence+
The fully automated Evidence+ analyzer is set to truly revolutionize laboratories worldwide. Continuing to provide high standards of quality, efficiency and reliability, the fully automated batch immunoanalyzer simultaneously detects multiple drugs and drug metabolites from a single sample.
The Evidence+ analyzer enables both efficient and cost-effective testing whilst providing accurate and reliable results to larger high throughput laboratories.
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimize waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralized platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
RIQAS – The World’s Largest International PT scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international PT provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programmes required whilst increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![QCMD banner](https://www.randox.com/wp-content/uploads/2019/12/QCMD-banner-.jpg)
![QCMD banner](https://www.randox.com/wp-content/uploads/2019/12/QCMD-banner-.jpg)
With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the field of molecular diagnostics.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
![Randox.com BANNER v2](https://www.randox.com/wp-content/uploads/2019/12/Randox.com-BANNER-v2-scaled.jpg)
![Randox.com BANNER v2](https://www.randox.com/wp-content/uploads/2019/12/Randox.com-BANNER-v2-scaled.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 117 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
Want to know more?
Contact us or book a meeting with us
Medica 2019
![landing page banner medica](https://www.randox.com/wp-content/uploads/2019/11/landing-page-banner-medica--scaled.jpg)
![landing page banner medica](https://www.randox.com/wp-content/uploads/2019/11/landing-page-banner-medica--scaled.jpg)
Join us for MEDICA 2019!
Randox Laboratories will be attending MEDICA 2019 from the 18th – 22nd November 2019. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the Messe Düsseldorf, Germany.
New Products
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
Acusera Infectious Disease Serology Controls
Randox Quality Control are pleased to announce the launch of our new Infectious Disease Serology Internal Quality Controls. Our portfolio includes Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more.
All samples are provided in a user-friendly, liquid ready-to-use format. This significantly reduces preparation time and the risk of pipetting errors.
There is approximately 1 million people in the USA living with HIV and around 15% of them are unaware they are infected (CDC, March 2019). Furthermore, the Centers for Disease Control and Prevention (CDC) estimate that around 39,000 new HIV infections are reported per year.
The impact of not only HIV but all infectious diseases is getting much greater. Therefore, laboratories now play a much more important role in providing accurate test results. This is a key component in controlling the spread of infections.
Reporting a false positive result has its own obvious implications, however, what about the consequences of reporting a false negative. This can be just as devastating to a person in terms of the treatment they will receive and even personal lifestyle changes for the patient in question.
![Reagents Adipondectin medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Adipondectin-medica.jpg)
![Reagents Adipondectin medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Adipondectin-medica.jpg)
Adiponectin
Adiponectin (adipocyte complement-related protein of 30kDa (Acrp30)) is an adipokine (protein hormone) produced and secreted by the adipose tissue, an endocrine organ. Adiponectin acts as a messenger in the communication of adipose tissue and metabolic organs. In doing so, Adiponectin suppresses the production of glucose in the liver through inhibiting the genes involved in glucose production and enhances fatty acid oxidation in skeletal muscle 2. Consequently, Adiponectin is a strong protector against several pathological events in various cells through inhibiting inflammation, suppressing cell death and enhancing cell survival. Adiponectin has been identified as having pleiotropic functions widely associated with anti-atherogenic, anti-diabetic, cardioprotective and anti-inflammatory effects.
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
Randox Stroke Biochip
The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.
Using Randox revolutionary patented Biochips, the Randox Stroke Biochip provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.
Benefits of the Randox Stroke Biochip
> Multiplex biochip for rapid stroke classification in under 30 minutes from a single plasma sample
> Complements and enhances existing CT scanning ensuring fast and accurate diagnosis
> Fast and accurate diagnostic classification between ischaemic and haemorrhagic stroke
> Simple 2 step process from sample entry to results
> Ensures better outcomes guaranteeing timely therapeutic intervention
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
The new Evidence+
The fully automated Evidence+ analyzer is set to truly revolutionize laboratories worldwide. Continuing to provide high standards of quality, efficiency and reliability, the fully automated batch immunoanalyzer simultaneously detects multiple drugs and drug metabolites from a single sample.
The Evidence+ analyzer enables both efficient and cost-effective testing whilst providing accurate and reliable results to larger high throughput laboratories.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Reagents Hfab medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab-medica.jpg)
![Reagents Hfab medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab-medica.jpg)
![Reagents Hfab medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab-medica.jpg)
H-FABP in CSA-AKI Testing
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a well-recognised postoperative complication of cardiac surgery and is the second most common cause of AKI in the ICU, occurring in up to 30% of patients. Higher pre-operative values of H-FABP were associated with a higher risk of developing AKI. Following adjustments of certain patient characteristics, the association of pre-operative H-FABP with the development of AKI remained significant. In fact, the researchers observed that a 1 unit increase in log H-FABP was associated with a 3-fold increase in the odds of developing AKI.
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimize waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralized platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
RIQAS – The World’s Largest International PT scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international PT provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programmes required whilst increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
![Reagents Hfab medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab-medica.jpg)
![Reagents Hfab medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab-medica.jpg)
![Reagents Hfab medica](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab-medica.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 111 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, drugs of abuse testing, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
Want to know more?
Contact us or book a meeting with us
APFCB 19
![15th APFCB web banner](https://www.randox.com/wp-content/uploads/2019/10/15th-APFCB-web-banner-scaled.jpg)
![15th APFCB web banner](https://www.randox.com/wp-content/uploads/2019/10/15th-APFCB-web-banner-scaled.jpg)
Join us for the 15th APFCB Congress 2019!
Randox Laboratories will be attending the 15th APFCB from the 17th – 20th November 2019. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the new Jaipur Exhibition & Convention Centre stand P1.
New Products
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
Acusera Infectious Disease Serology Controls
Randox Quality Control are pleased to announce the launch of our new Infectious Disease Serology Internal Quality Controls. Our portfolio includes Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more.
All samples are provided in a user-friendly, liquid ready-to-use format. This significantly reduces preparation time and the risk of pipetting errors.
There is approximately 1 million people in the USA living with HIV and around 15% of them are unaware they are infected (CDC, March 2019). Furthermore, the Centers for Disease Control and Prevention (CDC) estimate that around 39,000 new HIV infections are reported per year.
The impact of not only HIV but all infectious diseases is getting much greater. Therefore, laboratories now play a much more important role in providing accurate test results. This is a key component in controlling the spread of infections.
Reporting a false positive result has its own obvious implications, however, what about the consequences of reporting a false negative. This can be just as devastating to a person in terms of the treatment they will receive and even personal lifestyle changes for the patient in question.
![Reagents Adipondectin](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Adipondectin.jpg)
![Reagents Adipondectin](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Adipondectin.jpg)
Adiponectin
Adiponectin (adipocyte complement-related protein of 30kDa (Acrp30)) is an adipokine (protein hormone) produced and secreted by the adipose tissue, an endocrine organ. Adiponectin acts as a messenger in the communication of adipose tissue and metabolic organs. In doing so, Adiponectin suppresses the production of glucose in the liver through inhibiting the genes involved in glucose production and enhances fatty acid oxidation in skeletal muscle 2. Consequently, Adiponectin is a strong protector against several pathological events in various cells through inhibiting inflammation, suppressing cell death and enhancing cell survival. Adiponectin has been identified as having pleiotropic functions widely associated with anti-atherogenic, anti-diabetic, cardioprotective and anti-inflammatory effects.
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
Randox Stroke Biochip
The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.
Using Randox revolutionary patented Biochips, the Randox Stroke Biochip provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.
Benefits of the Randox Stroke Biochip
> Multiplex biochip for rapid stroke classification in under 30 minutes from a single plasma sample
> Complements and enhances existing CT scanning ensuring fast and accurate diagnosis
> Fast and accurate diagnostic classification between ischaemic and haemorrhagic stroke
> Simple 2 step process from sample entry to results
> Ensures better outcomes guaranteeing timely therapeutic intervention
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
The new Evidence+
The fully automated Evidence+ analyzer is set to truly revolutionize laboratories worldwide. Continuing to provide high standards of quality, efficiency and reliability, the fully automated batch immunoanalyzer simultaneously detects multiple drugs and drug metabolites from a single sample.
The Evidence+ analyzer enables both efficient and cost-effective testing whilst providing accurate and reliable results to larger high throughput laboratories.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Reagents Hfab](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab.jpg)
![Reagents Hfab](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab.jpg)
![Reagents Hfab](https://www.randox.com/wp-content/uploads/2019/11/Reagents-Hfab.jpg)
H-FABP in CSA-AKI Testing
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a well-recognised postoperative complication of cardiac surgery and is the second most common cause of AKI in the ICU, occurring in up to 30% of patients. Higher pre-operative values of H-FABP were associated with a higher risk of developing AKI. Following adjustments of certain patient characteristics, the association of pre-operative H-FABP with the development of AKI remained significant. In fact, the researchers observed that a 1 unit increase in log H-FABP was associated with a 3-fold increase in the odds of developing AKI.
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimize waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralized platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
RIQAS – The World’s Largest International PT scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international PT provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programmes required whilst increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 111 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, drugs of abuse testing, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
Want to know more?
Contact us or book a meeting with us
IBMS 19
![IBMS bannerindd](https://www.randox.com/wp-content/uploads/2019/07/IBMS-bannerindd-scaled.jpg)
![IBMS bannerindd](https://www.randox.com/wp-content/uploads/2019/07/IBMS-bannerindd-scaled.jpg)
Join us for IBMS 2019!
Randox Laboratories will be attending IBMS from the 23rd – 25th September 2019. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the International Convention Centre, Birmingham at stand 407.
New Products
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
Acusera Infectious Disease Serology Controls
Randox Quality Control are pleased to announce the launch of our new Infectious Disease Serology Internal Quality Controls. Our portfolio includes Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more.
All samples are provided in a user-friendly, liquid ready-to-use format. This significantly reduces preparation time and the risk of pipetting errors.
![HbA1c - (RANDOX WEBSITE)](https://www.randox.com/wp-content/uploads/2019/09/HbA1c-RANDOX-WEBSITE.jpg)
![HbA1c - (RANDOX WEBSITE)](https://www.randox.com/wp-content/uploads/2019/09/HbA1c-RANDOX-WEBSITE.jpg)
Randox Laboratories has this month announced its achievement in being awarded the Manufacturer Certification by the National Glycohemoglobin Standardization Program (NGSP); for direct HbA1c testing on three of its clinical chemistry analysers; the RX modena, RX imola and RX daytona+.
NGSP is recommended for laboratories conducting diabetes-related clinical trials and is only granted on the basis of 98% accuracy. With the global prevalence of diabetes mellitus increasing rapidly, affecting roughly 8% of the total population, the achievement of this certification emphasises that Randox RX series clinical chemistry analysers correlate with global standards and deliver accurate, reliable and precise results for direct HbA1c testing; helping clinicians make informed decisions for patients with diabetes.
The Randox automated immunoturbidmetric HbA1c test exhibits high accuracy and reproducibility with the added advantages of using liquid reagents with good stability, and on-board pre-treatment of samples; therefore, offering an improved method for the rapid direct measurement of HbA1c in human blood.
Randox Direct HbA1c Assay Features
> Sample type – suitable for use with whole blood samples
> Latex enhanced immunoassay method – the Randox assay utilises an immunoassay method making it simple and quick to perform
> Liquid ready to use reagents – for ease of use and convenience
> Excellent stability – all reagents are stable to expiry date when stored at +2-8ºC or 28 days on board the analyser at approximately 10°C
Advantages of the RX series Direct HbA1c Testing
> Fully automated on-board haemolysis function for HbA1c testing
> Continuous loading and STAT sample functionality to enhance productivity in the laboratory (analyser dependent)
> Low sample volumes required
> 1200 tests per hour including ISE (RX modena)
Randox was awarded NGSP Certification for Direct HbA1c testing on 1st July 2019.
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
Randox Stroke Biochip
The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.
Using Randox revolutionary patented Biochips, the Randox Stroke Biochip provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.
Benefits of the Randox Stroke Biochip
> Multiplex biochip for rapid stroke classification in under 30 minutes from a single plasma sample
> Complements and enhances existing CT scanning ensuring fast and accurate diagnosis
> Fast and accurate diagnostic classification between ischaemic and haemorrhagic stroke
> Simple 2 step process from sample entry to results
> Ensures better outcomes guaranteeing timely therapeutic intervention
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
The new Evidence+
The fully automated Evidence+ analyzer is set to truly revolutionize laboratories worldwide. Continuing to provide high standards of quality, efficiency and reliability, the fully automated batch immunoanalyzer simultaneously detects multiple drugs and drug metabolites from a single sample.
The Evidence+ analyzer enables both efficient and cost-effective testing whilst providing accurate and reliable results to larger high throughput laboratories.
![reagents banner](https://www.randox.com/wp-content/uploads/2019/09/reagents-banner-scaled.jpg)
![reagents banner](https://www.randox.com/wp-content/uploads/2019/09/reagents-banner-scaled.jpg)
Revealing H-FABP for AKI Testing
A new testing application for the biomarker heart-type fatty acid-binding protein (H-FABP) has been announced by global diagnostic company Randox Laboratories.
Whilst H-FABO is most commonly recognised as an early biomarker of myocardial infarction, the assay’s clinical utility in cardiac surgery-associated acute kidney injury (CSA-AKI) is notable. Studies have shown that patients who developed AKI following cardiac surgery had elevated levels of H-FABP both pre-and post-operatively compared to patients who did not.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
Register your attendance at our workshop
Advances in Quality Control - Tools to calculate Measurement Uncertainty | Room 116 | Mon 23 September, 11am - 12pm
ISO 15189:2012 requires laboratories to determine Measurement Uncertainty (MU) for each measurement procedure and regularly review estimates of MU. In this session, Margaret will explore these requirements focusing on what is MU, how MU is calculated and tools available to assist laboratories in meeting these requirements.
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimize waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralized platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
RIQAS – The World’s Largest International PT scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international PT provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programmes required whilst increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/07/QCMD-002-1024x287.jpg)
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/07/QCMD-002-1024x287.jpg)
Molecular External Quality Control
QCMD is a world leading External Quality Assessment (EQA) / Proficiency Testing (PT) scheme, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases. With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the field of infectious disease testing.
EQA participants receive an individual report outlining their performance relative to their method and technology groups. A supplementary report may be commissioned – this includes any additional relevant information regarding the annual EQA distribution, as well as scientific expert commentary and feedback on the overall results within that distribution.
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 111 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, drugs of abuse testing, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
Want to know more?
Contact us or book a meeting with us
AACC 19
![AACC Website Banner - 2019 ++](https://www.randox.com/wp-content/uploads/2019/07/AACC-Website-Banner-2019-.jpg)
![AACC Website Banner - 2019 ++](https://www.randox.com/wp-content/uploads/2019/07/AACC-Website-Banner-2019-.jpg)
Join us for AACC 2019!
Randox Laboratories will be attending AACC from the 6th – 8th August 2019. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the Anaheim Convention Centre at stand 1101.
New Products
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
![Serology QC website banners JUN19](https://www.randox.com/wp-content/uploads/2019/06/Serology-QC-website-banners-JUN19-scaled.jpg)
Acusera Infectious Disease Serology Controls
Randox Quality Control are pleased to announce the launch of our new Infectious Disease Serology Internal Quality Controls. Our portfolio includes Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more.
All samples are provided in a user-friendly, liquid ready-to-use format. This significantly reduces preparation time and the risk of pipetting errors.
There is approximately 1 million people in the USA living with HIV and around 15% of them are unaware they are infected (CDC, March 2019). Furthermore, the Centers for Disease Control and Prevention (CDC) estimate that around 39,000 new HIV infections are reported per year.
The impact of not only HIV but all infectious diseases is getting much greater. Therefore, laboratories now play a much more important role in providing accurate test results. This is a key component in controlling the spread of infections.
Reporting a false positive result has its own obvious implications, however, what about the consequences of reporting a false negative. This can be just as devastating to a person in terms of the treatment they will receive and even personal lifestyle changes for the patient in question.
![EuroMedlab3 RX daytona+ FDA banner](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab3-RX-daytona-FDA-banner-1024x280.jpg)
![EuroMedlab3 RX daytona+ FDA banner](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab3-RX-daytona-FDA-banner-1024x280.jpg)
Daytona+
At this year’s AACC, Randox are pleased to announce 510 (K) clearance from the U.S. Food and Drug Administration for the RX daytona+ clinical chemistry analyzer. Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants, diabetes and veterinary testing. Guaranteeing real cost savings through consolidation of routine and specialized tests onto a single platform, the RX series of analyzers offers excellence in patient care, delivering unrivalled precision, accuracy and reliability.
The RX daytona+ fully automated, benchtop, clinical chemistry analyzer is capable of performing high quality testing including emergency STAT sampling and boasts a combined throughput of 450 tests per hour including ISE. The most versatile chemistry analyzer in its class, the RX daytona+ presents laboratories with a range of benefits offering optimum performance, unrivalled uptime, flexibility, efficiency and functionality.
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
![EuroMedlab5](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab5-scaled.jpg)
Randox Stroke Biochip
The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.
Using Randox revolutionary patented Biochips, the Randox Stroke Biochip provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.
Benefits of the Randox Stroke Biochip
> Multiplex biochip for rapid stroke classification in under 30 minutes from a single plasma sample
> Complements and enhances existing CT scanning ensuring fast and accurate diagnosis
> Fast and accurate diagnostic classification between ischaemic and haemorrhagic stroke
> Simple 2 step process from sample entry to results
> Ensures better outcomes guaranteeing timely therapeutic intervention
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
![EuroMedlab4 Evidence +](https://www.randox.com/wp-content/uploads/2019/06/EuroMedlab4-Evidence--scaled.jpg)
The new Evidence+
The fully automated Evidence+ analyzer is set to truly revolutionize laboratories worldwide. Continuing to provide high standards of quality, efficiency and reliability, the fully automated batch immunoanalyzer simultaneously detects multiple drugs and drug metabolites from a single sample.
The Evidence+ analyzer enables both efficient and cost-effective testing whilst providing accurate and reliable results to larger high throughput laboratories.
![Spla2](https://www.randox.com/wp-content/uploads/2019/05/Spla2-scaled.jpg)
![Spla2](https://www.randox.com/wp-content/uploads/2019/05/Spla2-scaled.jpg)
Enhance your Cardiac Testing Panel with sPLA2-IIA!
Randox are pleased to announce the new automated assay for sPLA2-IIA mass. sPLA2-IIA is thought to be the most highly expressed enzyme from the secretory phospholipase A2 family. sPLA2-IIA is expressed in the normal arterial wall and its expression is readily up-regulated by inflammatory stimuli. It’s production of fatty acids and biologically active phospholipids plays an important role in platelet, monocyte, and endothelial activation, processes known to be critical steps in atherogenesis.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimize waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralized platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
RIQAS – The World’s Largest International PT scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international PT provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programmes required whilst increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 111 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, drugs of abuse testing, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
Want to know more?
Contact us or book a meeting with us
View our list of scientific posters that will be on display at AACC
Development of a Duplex Biochip Assay for the Simultaneous Detection of Anti-thyroglobulin and Anti-thyroid Peroxidase Antibodies on the Fully Automated Evidence Evolution Analyser | Display time: 12.30pm-1.30pm | Presenter: A. Jennings (RCLS)
Development of a New Biochip Based Immunoassay for the Detection of Parathyroid Hormone Applied to the Evidence Evolution Analyser | Display time: 12.30pm-1.30pm | Presenter: H. Winter (Randox R&D)
Human Based Liquid Frozen Multi-Analyte Linearity Verification Material Covering Five Levels of Lipid Profile Components for Accurate Assessment of the Test System Reportable Range | Display time: 12.30pm-1.30pm | Presenter: L. Adams (Randox Laboratories Ltd.)
Development and Evaluation of a Fully-Automated Multiplex Molecular Test for the Detection of Common Causative Agents of Urinary Tract Infections | Display time: 12.30pm-1.30pm | Presenter: M.K. Higgings (Randox R&D Molecular Biology)
Evaluation of a Latex Enhanced Immunoturbidimetric Assay Kit for the Rapid Direct On-Board Measurement of Glycated Haemoglobin (%HbA1c) on the RX daytona + Analyser | Display time: 12.30pm-1.30pm | Presenter: E. Lenehan (Randox Laboratories Ltd)
Development of Monoclonal Antibodies to Chromogranin A, a Biomarker for Neuroendocrine Dysfunction | Display time: 12.30pm – 1.30pm | Presenter: H. Winter (Randox R&D)
Development of Monoclonal Antibodies to Pancreastatin, a Biomarker for Neuroendocrine Dysfunction | Display time: 12.30pm – 1.30pm | Presenter: E. Mathers (Randox R&D)
Development of New Biochip Arrays for the Determination of Five Biomarkers Related to Acute Kidney Injury Applied to the Evidence Investigator Analyser | Display time: 12.30pm-1.30pm | S. O’Donnell (Randox Teoranta R&D)
Africa Health 2019
![Africa Health 2019](https://www.randox.com/wp-content/uploads/2019/05/Africa-Health-2019-scaled.jpg)
![Africa Health 2019](https://www.randox.com/wp-content/uploads/2019/05/Africa-Health-2019-scaled.jpg)
Join us for Africa Health 2019!
Randox Laboratories will be attending Africa Health from the 28th – 30th May 2019. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the Gallagher Convention Centre in Johannesburg , at our stand #4.D16.
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Acusera
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimise waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Acusera 24.7
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralised platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Acusera Verify
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
The World’s Largest International EQA scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international EQA provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programs required while increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/05/QCMD-002.jpg)
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/05/QCMD-002.jpg)
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/05/QCMD-002.jpg)
Molecular External Quality Control
QCMD is a world leading External Quality Assessment (EQA) / Proficiency Testing (PT) scheme, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases. With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the field of infectious disease testing.
EQA participants receive an individual report outlining their performance relative to their method and technology groups. A supplementary report may be commissioned – this includes any additional relevant information regarding the annual EQA distribution, as well as scientific expert commentary and feedback on the overall results within that distribution.
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 113 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, drugs of abuse testing, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL2/3 Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
Enhance your Cardiac Testing Panel with sPLA2-IIA!
sPLA2-IIA is thought to be the most highly expressed enzyme from the secretory phospholipase A2 family. sPLA2-IIA is expressed in the normal arterial wall and its expression is readily up-regulated by inflammatory stimuli. It’s production of fatty acids and biologically active phospholipids plays an important role in platelet, monocyte, and endothelial activation, processes known to be critical steps in atherogenesis.
![RX series Analysers](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers.jpg)
![RX series Analysers](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
Want to know more?
Contact us or book a meeting with us
EuroMedLab 2019
![EuroMedlab Banner](https://www.randox.com/wp-content/uploads/2019/04/EuroMedlab-Banner-e1557230021325-scaled.jpg)
![EuroMedlab Banner](https://www.randox.com/wp-content/uploads/2019/04/EuroMedlab-Banner-e1557230021325-scaled.jpg)
Join us for EuroMedLab 2019!
Randox Laboratories will be attending EuroMedLab from the 19th – 23rd May 2019. Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.
Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in the Barcelona International Convention Centre, at our booth No. 184.
Register your attendance at one of our industry sponsored workshops
The industry specific workshops are open to all congress attendees on a first come, first-served basis.
Development and clinical evaluation of an automated multi-analyte biochip array for rapid stroke diagnosis | Room 116 | Mon, 20 May 2019 , 14:45 – 15:45
Secreted Phospholipases A2 and Cardiovascular Risk | Room 116 | Tue, 21 May 2019 , 12:30 – 13:30
Novel Multiplex Molecular Diagnostics: A Cross-Platform Comparison | Room 117 | Tue, 21 May 2019, 14:45 – 15:45
What can we offer?
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
![AACC-Vivalytic-Banner-MAY18 vivalytic](https://www.randox.com/wp-content/uploads/2019/04/AACC-Vivalytic-Banner-MAY18.jpg)
Randox Biosciences is part of Randox Laboratories and is dedicated to advancing scientific discovery, drug development and diagnostics. We provide a variety of services and products to numerous industries including clinical laboratories, biopharma and academic research institutes.
Our revolutionary multiplex Biochip Array Technology includes multiplex protein immunoassays and multiplex nucleic acid arrays, and is delivered via the award winning Evidence range of analysers. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format.
Vivalytic
Vivalytic the newest offering from Randox Biosciences brings innovation to the Molecular Diagnostic industry providing tests for respiratory, genitourinary and hospital acquired infections. The Vivalytic platform is capable of both Hi-Plex and Lo-Plex testing. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary, fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required making Vivalytic a unique space-saving, hygienic solution for Molecular Diagnostic testing.
Join our workshop on Tuesday 21st May 2019 to learn more about molecular testing and how 44 pathogens can be tested from a single patient sample.
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - QC](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-QC-1-scaled.jpg)
Acusera
Leading provider of true third-party controls
With over 390 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover, the availability of truly independent third-party controls coupled with the added advantages of highly accurate target values, excellent stability and unparalleled quality will enhance performance, save valuable time and minimise waste in any laboratory. Our comprehensive range of multi-analyte controls have been uniquely developed with user convenience in mind. By combining more than 100 parameters in a single vial, laboratories can significantly reduce the need for multiple, costly single analyte controls.
Acusera 24.7
Online QC software with real-time peer group statistics
Designed to help you efficiently review QC data from multiple laboratory instruments on one centralised platform, Acusera 24.7 allows quick and easy identification of QC failures and emerging trends.
Unique access to live peer group updates will reduce time and money spent troubleshooting, helping you to instantly discover if an issue is isolated to your lab or a widespread problem. The added benefit of automatically generated statistics including Sigma Scores, Measurement Uncertainty & Total Error as well as fully interactive charts & reports will enable quick and easy performance monitoring.
Acusera Verify
Meet CLIA requirements with accuracy and ease
Acusera Linearity Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format, while also presented in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.
Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment. Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review.
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
![Euro MedLab QC website banners MAY19 - RIQAS](https://www.randox.com/wp-content/uploads/2019/05/Euro-MedLab-QC-website-banners-MAY19-RIQAS-1-scaled.jpg)
The World’s Largest International EQA scheme
With over 45,000 laboratory participants in more than 133 countries, the Randox International Quality Assessment Scheme (RIQAS) is truly the largest international EQA provider in the world. Our comprehensive product offering currently covers over 360 parameters across 33 flexible programmes. Each RIQAS programme contains a unique combination of parameters meaning laboratories can significantly reduce the number of individual programs required while increasing efficiency and reducing costs. Further benefits to a laboratory include accreditation to ISO 17043:2010, frequent reporting, reduced parameter options and access to comprehensive yet user-friendly reports.
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
![Qnostics-002](https://www.randox.com/wp-content/uploads/2019/05/Qnostics-002.jpg)
Molecular Infectious Disease Controls
Qnostics is a leading manufacturer of Third Party Quality Control solutions for Molecular Infectious Disease testing. Supplying microbiology/virology laboratories, molecular diagnostic assay manufacturers, EQA providers, pharmaceutical and CRO organisations for over a decade.
Designed to meet the demand of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), the Qnostics Molecular Infectious Disease range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Infections, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Diseases and Central Nervous System Diseases.
Join our workshop on Tuesday 21st May 2019 to learn more about molecular testing and how 44 pathogens can be tested from a single patient sample.
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/05/QCMD-002.jpg)
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/05/QCMD-002.jpg)
![QCMD-002](https://www.randox.com/wp-content/uploads/2019/05/QCMD-002.jpg)
Molecular External Quality Control
QCMD is a world leading External Quality Assessment (EQA) / Proficiency Testing (PT) scheme, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases. With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the field of infectious disease testing.
EQA participants receive an individual report outlining their performance relative to their method and technology groups. A supplementary report may be commissioned – this includes any additional relevant information regarding the annual EQA distribution, as well as scientific expert commentary and feedback on the overall results within that distribution.
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
![Randox.com Website Banner](https://www.randox.com/wp-content/uploads/2019/04/Randox.com-Website-Banner-.jpg)
Randox Reagents are internationally recognised as being of the highest quality, offering reliable and rapid results. Our product portfolio consists of 113 clinical chemistry assays, covering a range of testing panels, including: antioxidants, diabetes, drugs of abuse testing, cardiology and lipids, specific proteins, therapeutic drug monitoring and veterinary testing.
Randox are continuously striving to improve diagnostic solutions worldwide. As a result, Randox have produced 29 niche and superior performance assays, including: 5th Generation Bile Acids, Adiponectin, Aldolase, Copper, Cystatin C, D-3-Hydroxybutyrate, G6PDH, H-FABP, Lipoprotein (a), NEFA, HDL2/3 Cholesterol, sdLDL Cholesterol, Total Antioxidant Status and Zinc.
Enhance your Cardiac Testing Panel with sPLA2-IIA!
sPLA2-IIA is thought to be the most highly expressed enzyme from the secretory phospholipase A2 family. sPLA2-IIA is expressed in the normal arterial wall and its expression is readily up-regulated by inflammatory stimuli. It’s production of fatty acids and biologically active phospholipids plays an important role in platelet, monocyte, and endothelial activation, processes known to be critical steps in atherogenesis.
Join our workshop on Tuesday 21st May 2019 to learn more about sPLA2-IIA’s role in inflammatory conditions, including its prediction in cardiovascular risk.
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
![RX series Analysers updated](https://www.randox.com/wp-content/uploads/2019/05/RX-series-Analysers-updated.jpg)
Renowned for quality and reliability, the RX series leads the way with the world’s most extensive dedicated clinical chemistry test menu comprising routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants, veterinary and diabetes testing. Guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform, the RX series of analysers delivers excellence in patient care, offering unrivalled precision, accuracy and reliability.
RX misano
The RX misano semi-automated analyser has been developed with the user in mind by incorporating a responsive touch-screen display. The sleek ergonomic design boasts intuitive user-friendly software allowing for test menu personalisation and ease of use. The RX misano is capable of high standard, precise results at a competitive price per test.
RX monaco
The RX monaco is a fully automated solution for low to mid volume clinical chemistry testing offering the ultimate in convenience, performance and confidence. At optimal configuration, the RX monaco performs 170 tests per hour providing cost effective, high quality testing.
RX daytona +
The RX daytona+ is a fully automated, benchtop, clinical chemistry analyser capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyser in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivalled performance with direct HbA1c testing capabilities.
RX imola
The RX imola is a cost-effective system that delivers consistent high-quality results. Capable of handling the workload of a medium to high throughout laboratory and a combined throughput of 560 tests per hour, the RX imola provides rapid, comprehensive testing on a small footprint analyser with direct HbA1c testing capabilities. The RX imola is a fully automated system with random access and STAT sampling functionality, boosting productivity and saving time when it matters most
RX modena
Capable of performing up to 1,200 tests per hour, with direct HbA1c testing capabilities, the RX modena consolidates all your assay requirements onto one intuitive platform. The RX modena boasts icon based, interactive touch-screen technology adding a modern flair to your laboratory.
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
![multistat](https://www.randox.com/wp-content/uploads/2019/05/multistat.png)
Randox Toxicology offer the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing market influences and develop assays for current and novel drug trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
![Evidence banner2](https://www.randox.com/wp-content/uploads/2019/05/Evidence-banner2-scaled.jpg)
Evidence series immunoassay analysers guarantee cost-effective, highly accurate and flexible testing solutions. Having been developed to work with patented Biochip Array Technology, this precision multiplex testing platform allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.
This multiplex system delivers an unrivalled increase in patient information, offering a more in-depth diagnostic profile with each patient sample. This further analysis places the focus on the diagnosis, and on improving patient outcomes.
Want to know more?
Contact us or book a meeting with us
View our list of scientific posters that will be on display at EuroMedLab
Rapid simultaneous screening (less than 23 minutes) of twenty drug classes from a single whole blood sample on the biochip analyser Evidence MultiSTAT | Display time: 10.00am – 5.30pm | Presenter: P. Robinson (Randox Toxicology)
Evaluation of the effect of more frequent reporting in analytical performance through the use of an international external quality assessment scheme | Display time: 10.00am – 5.30pm | Presenter: L. Adams (Randox Laboratories Ltd.)
Development of a biochip array for the simultaneous detection of twelve cytokines on the new random access fully automated Evidence Evolution analyser | Display time: 10.00am – 5.30pm | Presenter: G. Donnellan (Randox Teoranta)
Analytical performance evaluation of an assay for the direct measurement of HbA1c in whole blood on RX series analysers of different throughput | Display time: 10.00am – 5.30pm | Presenter: E. Lenehan (Randox Laboratories Ltd)
Development of a new biochip based immunoassay for the determination of the bone formation biomarker N-terminal propeptide of type 1 collagen (P1NP) | Display time: 10.00am – 5.30pm | Presenter: H. Stott (R&D Randox Biosciences)
Development of a biochip-based immunoassay for the specific detection of the Wnt signalling antagonist DKK1 | Display time: 10.00am – 5.30pm | Presenter: H. Stott (R&D Randox Biosciences)
Development of a highly specific monoclonal antibody pair for the detection of sclerostin, a regulator of bone turnover | Display time: 10.00am – 5.30pm | A. Connolly (Randox Teoranta)
Biomarker glycosylation evaluation in pancreatic cancer utilizing biochip array technology | Display time: 10.00am – 5.30pm | A. Connolly (Randox Teoranta)
Featured Reagent – G6PDH
Featured Reagent | G6PDH
Back to Reagents Resource Hub>
Glucose-6-phosphate dehydorgenase (G6PDH/G6PD) deficiency is an x-linked and sex-linked metabolic disorder, commonly affecting men more so than women1. The G6PDH enzyme is critical for the proper functioning of red blood cells (RBC’s). Depleated levels of G6PDH can cause the premature destruction of RBC’s (haemolysis). If the bone marrow cannot compensate for the reduction in RBC’s, heamolyic anaemia can develop. It is important to note that a deficiency in the G6PDH enzyme is not enough to promote the onset of haemolysis, but rather additional factors are required to promote the onset of symptoms2.
Some of the common side effects of G6PDH deficiency include: paleness, dark urine, yellowing of the skin and whites of the eyes, a rapid heart rate and shortness of breath. Common triggers for the development of haemolytic anaemia in those who are G6PDH deficient include: bacterial and viral infections, certain drugs (medications and antibiotics to treat malaria), and favism (inhaling the pollen from fava plants and ingesting fava beans)3
G6PDH deficiency has been recognised as a significant cause of mild to severe jaundice in newborns. It has been noted that those with this disorder commonly will not experience any signs or symptoms making them unaware that they have the condition3.
Haemolytic Anaemia
Haemolytic anaemia is an umbrella term used to describe the premature destruction of red blood cells (RBC’s). This disorder encompasses numerous conditions including: autoantibodies, medications, underlying malignancy, bone marrow failure, infection and heredity conditions including sickle cell disease or haemoglobinopathies4 5.
The severity of haemolytic anaemia depends on whether the onset of haemolysis is gradual or rapid and on the extent of RBC destruction. Patients with mild haemolysis can be asymptomatic whereas the anaemia in severe haemolysis can be life-threatening and can cause angina and cardiopulmonary decompensation. Haemolytic anaemia is an intravascular phenomenon meaning that this type of haemolysis occurs within the blood vessels and is caused by the following conditions: prosthetic cardiac valves, glucose-6-phosphate dehydrogenase (G6PDH) deficiency, thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, transfusion of ABO incompatible blood and paroxysmal nocturnal haemoglobinuria (PNH)6.
Heredity disorders can also cause haemolysis due to the erythrocyte membrane and haemoglobin abnormalities, and enzymatic defects. Some hereditary disorders include: G6PDH deficiency, hereditary spherocytosis and sickle cell anaemia6.
Glucose-6-phosphate dehydrogenase (G6PDH) is a cytosolic enzyme located on the X-chromosome found in bodily cells. G6PDH is involved in the normal processing of carbohydrates and plays a critical role in RBC, protecting them from damage and premature destruction. The two main products of G6PDH are ribose-5-phosphate which is important for DNA, the chemical cousin of RNA. The chemical reaction produces NADPH which protects bodily cells from reactive oxygen species1.
Benefits of the G6PDH Assay
A niche assay from Randox meaning that Randox are one of the only manufacturers to offer a G6PDH assay in an automated biochemistry format.
Superior stability of 4 weeks upon reconstitution and stored at +2°C to +8°C. Many other commercially available assays offer only 5 days stability, leading to product wastage.
Minimal interference as the sample pre-wash step included in the Randox G6PDH testing method serves to purify the sample, leading to no known interferences being observed.
Excellent correlation coefficient of r=0.99 when compared against other commercially available methods.
Lyophilised reagent for enhanced stability.
UV method
G6PDH controls offering a complete testing package.
Applications available detailing instrument-specific settings for the convenient use of the Randox G6PDH assay on a wide range of clinical chemistry analsyers.
References
[1] Croom, Edward. Progress in Molecular Biology and Translational Science. 2012. ISBN 9780124158139 / ISSN 1877-1173.
[2] National Organization for Rare Disorders. Glucose-6-Phosphate Dehydrogenase Deficiency. [Online] no date. [Cited: January 31, 2019.] https://rarediseases.org/rare-diseases/glucose-6-phosphate-dehydrogenase-deficiency.
[3] U.S. National Library of Medicine. Glucose-6-phosphate dehydrogenase deficiency. [Online] May 2017. [Cited: January 30, 2019.] https://ghr.nlm.nih.gov/condition/glucose-6-phosphate-dehydrogenase-deficiency.
[4] National Heart, Lung, and Blood Institute. Hemolytic Anemia. [Online] no date. [Cited: January 28, 2019.] https://www.nhlbi.nih.gov/health-topics/hemolytic-anemia.
[5] BMJ Publishing Group. Hemolytic anemia. BMJ Best Practice. [Online] March 2018. [Cited: January 28, 2019.] https://bestpractice.bmj.com/topics/en-us/98.
[6] Schick, Paul. Hemolytic Anemia. Medscape. [Online] December 29, 2018. [Cited: Janaury 28, 2018.] https://emedicine.medscape.com/article/201066-overview.
MORE FEATURED REAGENTS
Read more about the Randox range of assays
Niche Reagents – Zinc, Copper & Aldolase
Reagents | Zinc, Copper & Aldolase
Advancing Routine Testing with Randox Reagents
Randox offer an extensive range of 115 third party diagnostic reagents which are internationally recognised as being of the highest quality; producing accurate and precise results. Continually reinvesting in R&D, Randox continue to offer the opportunity to expand your test menu without expanding your lab. Not only does Randox offer superior performance assays, but also niche assays, meaning that Randox are one of the only manufacturers to offer the test in an automated biochemistry format.
Zinc
A niche assay from Randox meaning that Randox are one of the only manufacturers to offer a clinical chemistry zinc assay
Strong correlation with standard methods as the Randox zinc assay showed a correlation coefficient of r=0.9946 when compared against standard methods
A measuring range of 11.3 – 159 µmol/l for the comfortable and accurate detection of abnormal levels
Liquid ready-to-use reagents for convenience and ease-of-use
Stable to expiry date when stored at +15 to +25°C
Applications are available detailing instrument-specific settings for the convenient use of the Randox zinc assay on a wide range of clinical chemistry analysers
An essential trace metal and the only metal present in all enzyme classes, zinc is the second most abundant micronutrient in humans after iron. Zinc is required for a healthy immune system, a healthy growth rate during pregnancy, childhood and adolescence, wound health and synthesizing DNA. Zinc can modulate brain excitability and is vital in the synaptic plasticity of the brain which is thought to contribute towards memory and learning. Zinc has also been identified as a neurotoxin which suggests that zinc homeostasis is involved in the normal functioning of the central nervous system and the brain 1.
Zinc deficiency is identified as a malnutrition problem worldwide, especially in areas of high cereal intake and low animal food intake. However, other factors may contribute to low zinc levels including: the bioavailability of zinc, chronic illnesses such as diabetes, malignancy, hepatic disease and sickle cell disease. Higher zinc requirements have been identified in infants, children, adolescents, and pregnant and lactating women compared to adults. During periods of growth, zinc deficiency can result in growth failure. The most common organs affected by zinc deficiency clinically include: central nervous system, gastrointestinal, epidermal, skeletal, immune, and reproductive systems 2 3.
Copper
A niche assay from Randox meaning that Randox are one of the only manufacturers to offer a clinical chemistry copper assay
Exceptional correlation with standard methods as the Randox copper assay showed a correlation coefficient of r=0.99 when compared against standard methods
A wide measuring range of 6.6 – 86 µmol/l for the comfortable and accurate detection of abnormal levels
Lyophilised reagents for enhanced stability
Excellent stability of 2 weeks when stored at +2 to +8°C
Applications are available detailing instrument-specific settings for the convenient use of the Randox copper assay on a wide range of clinical chemistry analysers
An essential trace metal, copper is the third most abundant micronutrient in humans after iron and zinc. Copper is mainly found in the brain, liver, kidneys, heart and skeletal muscle with the highest quantities found in the liver and muscles. It aids in some of the key bodily functions including: the production of red blood cells, the maintenance of nerve cells and the immune system, the formation of collagen to absorb iron for energy production, and the formation of melanin, bone and connective tissue. Ceruloplasmin is the protein responsible for the transportation of copper around the body 4.
There are various health problems that can cause abnormal copper levels, however deficiency is less likely than toxicity because a normal diet contains plenty of copper including: organic meats, beans and wholegrains. Deficiency is more likely to occur in those who are malnourished, more likely children.
Deficiency more commonly occurs in premature babies, resulting in bone abnormalities and fractures. Menkes Disease is a rare inherited genetic disorder of copper metabolism and is characterised by sparse and kinky hair as children with this disorder are unable to absorb enough copper 5.
Toxicity can be caused by consuming too many dietary supplements high in copper, from drinking contaminated water, or from fungicides containing copper sulphates. Wilson disease is a rare inherited disorder that prohibits the liver from safely storing and excreting copper resulting in it seeping out of the liver and building up in the eyes, liver, kidneys and brain causing nerve damage, and if untreated, it can be fatal 6.
Aldolase
A niche assay from Randox meaning that Randox are one of the only manufacturers to offer a clinical chemistry aldolase assay
Excellent correlation coefficient of r=0.9917 when compared against other commercially available methods
A wide measuring range of 1.73 – 106 µmol/l for the comfortable and accurate detection of abnormal levels
Lyophilised reagents for enhanced stability
UV Method
Applications are available detailing instrument-specific settings for the convenient use of the Randox aldolase assay on a wide range of clinical chemistry analysers
There are three types of Aldolase enzymes that can be can be found throughout the body: A, B and C. It is responsible for converting glucose into energy.
A is primarily contained within the muscle and erythrocytes, whereas B is contained within the liver, enterocytes and kidney, and A and C can be found within the brain. Despite the Aldolase enzyme existing throughout the body, the highest concentration levels of it can be found in the liver and the skeletal muscle, although testing this enzyme is routinely used for skeletal muscle damage 7.
Elevated levels of type A aldolase in the blood can be found in patients with damage to the skeletal muscle as the result of a trauma which includes dermatpmyositis, infectious mononucleosis, muscular dystrophy, myocardial infarction, hepatic cancer due to the damaged cells triggering the release of A into the blood. On the other hand, the concentration levels of A in the blood remain normal in situations where weakness is caused as the result of a neurological disease such as multiple sclerosis. Measuring A concentration levels in the blood can therefore be used to determine the root cause of muscle weakness, whether muscle trauma or neurological myopathy, in patients 7.
Want to know more?
Contact us or download our High Performance Brochure
Related Products
Aldolase Control
Chemistry Control
EQA Scheme
Resource Hub
References
[1] Osredkar, Josko and Sustar, Natasa. Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance. 1, s.l. : Journal of Clinical Toxicology, 2011, Vol. 3.
[2] Jockers, Dr. David. How To Test Zinc Levels At Home. DrJockers.com. [Online] 2019. [Cited: November 28, 2018.] https://drjockers.com/test-zinc-levels-home/..
[3] Roohani, Nazanin, et al. Zinc and its importance for human health: An integrative review. National Center for Biotechnology Information. [Online] J Res Med Sci, February 18, 2013. [Cited: November 28, 2018.] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724376/..
[4] Nordqvist, Joseph. What are the health benefits of zinc? Medical News Today. [Online] December 5, 2017. [Cited: November 28, 2018.] https://www.medicalnewstoday.com/articles/263176.php.
[5] Macfarlane, Susan. Understanding Nutrient Ratios: Zinc/Copper. Susan Macfarlane. [Online] October 29, 2017. [Cited: November 28, 2018.] https://susanmacfarlanenutrition.com/understanding-nutrient-ratios-zinccopper/.
[6] National Center for Advancing Translational Sciences. Menkes disease. National Center for Advancing Translational Sciences. [Online] Genetic and Rare Disease Information Center, April 7, 2017. [Cited: November 30, 2018.] https://rarediseases.info.nih.gov/diseases/1521/menkes-disease.
[7] Berridge, Brian R, Van Vleet, John F and Herman, Eugene. Chapter 46 – Cardiac, Vascular, and Skeletal Muscle Systems. 2013.